NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead.
Dr. Martens shares plunged more than 30% Tuesday after the iconic British brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year.
Trading in Dr. Martens stock was temporarily halted on the London Stock Exchange early Tuesday as it sank to a record-low 0.64 pounds, according to FactSet.
That could translate into a sizeable hit to profits, with the company pointing to a base projected impact of 20 million pounds ($24.9 million) on pretax earnings year-over-year. In-season orders from wholesale customers could help ease U.S. revenue expectations, the company noted, but those are difficult to predict.
Man United's ENTIRE squad 'is up for sale'
Theatrical play in Athens unveils life after cancer
Remains of Li Keqiang Cremated in Beijing
Rolling Stones show no signs of slowing during latest tour in Texas
Nation urged to make greater use of geothermal energy
Car buyers report poor performance
Tragedy as Taylor Swift fan dies days before her 10th birthday
Partnerships urged to bolster content industry in Asia